research JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
This review examines clinical data on the efficacy and safety of JAK inhibitors used for immune-mediated conditions beyond rheumatoid arthritis, highlighting their potential therapeutic roles in various inflammatory diseases.

